Equality Impact Assessment (Guidance development) (PDF 263 KB)
History
A list of downloadable documents created during development.
Expected publication
Final appraisal determination
Draft guidance: 1
Draft scope documents
Equality impact assessment- scoping
-
Equality impact assessment- scoping
-
Hidradenitis suppurativa (moderate, severe) - adalimumab: draft scope for consultation (pre-referral) - January 2015
-
Hidradenitis suppurativa (moderate, severe) - adalimumab: draft scope for consultation (pre-referral) - January 2015
-
Hidradenitis suppurativa (moderate, severe) - adalimumab: provisional matrix (pre-referral) - January 2015
-
Hidradenitis suppurativa (moderate, severe) - adalimumab: provisional matrix (pre-referral) - January 2015
-